Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck

NCT02624999 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped PI changed institution

Conditions

Squamous Cell Carcinoma Head and Neck

Interventions

BIOLOGICAL: AlloVax™
DRUG: Cisplatin

Sponsor

Mirror Biologics, Inc.